Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Motor Activity 1Disease 1Depression 1Body Weight Changes 1Body Weight 1Anxiety Disorders 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Interventional × Professional Autonomy × Clear all
NCT02030353 2016-01-20

The Use of Smart Scales for Weight Gain Prevention in African American Breast Cancer Survivors

UNC Lineberger Comprehensive Cancer Center

Phase NA Completed
35 enrolled
Breast

Body Weight, Body Weight Changes, Breast Neoplasms

NCT02468050 2015-06-10

Study of Exercise to Manage Distress During Breast Screening

University of Western Ontario, Canada

Phase 2 Completed
7 enrolled
Breast

Anxiety Disorders, Breast Neoplasms, Depression, Disease, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡